Apotheka Pharma Vaistinė UAB Finance - revenue, profit
Financial ratios
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2024 |
|---|
| 7,488,378 |
| 154,368 |
| -3,670,873 |
| -3,670,873 |
| -75,673 |
| 18.31 |
| -49.02 |
| -13,368,831 |
| 15,427,709 |
| 316,972 |
| 1,752,522 |
| 2025 |
|---|
| 6,824,494 |
| 137,535 |
| -3,436,996 |
| -3,436,996 |
| -69,266 |
| 19.02 |
| -50.36 |
| -16,805,827 |
| 18,397,143 |
| 172,258 |
| 1,428,170 |
| 2026 |
|---|
| 7,949,433 |
| 162,300 |
| -3,269,680 |
| -3,269,680 |
| -66,755 |
| 18.61 |
| -41.13 |
| -20,075,508 |
| 21,838,324 |
| 146,814 |
| 1,608,480 |
Enjoy unlimited use
with Freemium unlimited| 2026 |
|---|
| 7,949,433 |
| 162,300 |
| -3,269,680 |
| -3,269,680 |
| -66,755 |
| 18.61 |
| -41.13 |
| -20,075,508 |
| 21,838,324 |
| 146,814 |
| 1,608,480 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2026
Turnover (€)
7,949,433 €16 % *
Sales per employee (€)
162,300 €18 % *
Profit before tax (€)
-3,269,680 €5 % *
Net Profit (€)
-3,269,680 €5 % *
Profit per employee (€)
-66,755 €4 % *
Total profitability (%)
18.61 %-2.16 % *
Net profitability (%)
-41.13 %18.33 % *
Equity (€)
-20,075,508 €-19 % *
Amounts Payable And Liabilities (€)
21,838,324 €19 % *
Non-current Assets (€)
146,814 €-15 % *
CurrentAssets (€)
1,608,480 €13 % *
